EW

Edwards Lifesciences Corp.

Price

$78.21

return (12m)

p/e

45.55

p/bv

4.82

DIVIDEND YIELD

0.00%

EW price

Edwards Lifesciences

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment EW

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals EW

Valuation

P/E

45.55

Sector -2.34

Industry 11.10

P/BV

4.82

Sector 2.17

Industry 3.33

P/Revenue (PSR)

7.90

Sector 2.00

Industry 1.71

EV/EBITDA

84.07

Sector -23.69

Industry -398.52

EV/EBIT

90.75

Sector -36.60

Industry -80.73

P/EBITDA

31.93

Sector -0.10

Industry 8.30

P/EBIT

35.61

Sector -2.08

Industry 5.69

P/Total Assets

3.74

Sector 1.18

Industry 1.57

P/Net Current Assets

15.39

Sector -10.91

Industry -3.38

P/Working Capital

10.33

Sector 0.09

Industry 10.51

EPS

1.89

Sector -0.93

Industry 1.10

BVPS

17.84

Sector 3.87

Industry 14.82

Efficiency

Gross Margin

77.87%

Sector 44.28%

Industry 29.23%

EBITDA Margin

33.70%

Sector -291.45%

Industry 4.29%

EBIT Margin

31.22%

Sector -195.44%

Industry 1.44%

Operating Margin

27.62%

Sector -25.72%

Industry 2.16%

Net Profit Margins

17.34%

Sector -30.19%

Industry 2.77%

Asset Turnover

0.12

Sector 0.12

Industry 0.27

Profitability

ROE

10.58%

Sector -34.71%

Industry 6.97%

ROA

8.20%

Sector -28.76%

Industry 2.97%

ROIC

20.30%

Sector -441.27%

Industry -5.31%

Dividends

Dividend yield

0.00%

Sector -

Industry 0.01%

Payout

0.00%

Sector -

Industry 0.54%

Debt

Current Ratio

4.42

Sector 1.87

Industry 1.51

Net Debt / EBITDA

-5.53

Sector -2.18

Industry -1.68

Net Debt / EBIT

-5.97

Sector -0.74

Industry -7.00

Net Debt / Equity

-0.30

Sector -0.34

Industry 0.05

Gross Debt / Equity

0.06

Sector -0.64

Industry 0.35

Equity/Assets

0.78

Sector 0.43

Industry 0.46

Liabilities/Assets

0.22

Sector 0.46

Industry 0.52

Growth

5Y Revenue CAGR

3.79%

Sector -

Industry -

5Y Earnings CAGR

-6.18%

Sector -

Industry -

FAIR VALUE OF Edwards Lifesciences ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$78.21

Fair Value

$27.54

Upside Return potential.

-64.78%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals EW

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
EW Edwards Lifesciences Corp.	$78.21	12.69%	0.00%	45.55	4.82	10.58%	17.34%
BSX Boston Scientific Corp.	$63.80	-31.89%	0.00%	18.45	2.54	13.78%	17.29%
ABT Abbott Laboratories	$101.06	-18.35%	0.00%	25.64	3.09	12.06%	13.91%
ABMD Abiomed Inc.	$0.00	-	0.00%	64.27	11.14	17.32%	24.84%
ALGN Align Technology Inc.	$184.69	12.52%	0.00%	27.86	2.89	10.36%	10.50%
BLPH Bellerophon Therapeutics Inc.	$0.00	-	0.00%	0.59	0.13	22.35%	0.00%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

EW Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Edwards Lifesciences

Edwards Lifesciences Corp.

Average Investor10 user rating

4.0 (1 people)

States of America

27 years

Founded: 1999

2000

Time since IPO - 26 years

14.900

Employees

Edwards Lifesciences Corp. (States of America) is listed on the NYSE and has a market capitalization of $49.78 billion, with shareholders equity totaling $10.33 billion.

The company employs approximately 14.900 people and operates in the Saúde sector, within the Materiais e Equipamentos Médicos industry.

Over the past 12 months, Edwards Lifesciences Corp. reported $6.30 billion in revenue, generating net income of $1.09 billion.

Key financial metrics include a P/E ratio of 45.55, a price-to-book (P/B) ratio of 4.82, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker EW.

Market cap

$49.78 billion

Net worth

$10.33 billion

$10,327,500,000.00

Assets

$13.32 billion

$13,321,200,000.00

Total Shares Outstanding

579.00 million

579,000,000

Average Daily Trading Volume

$4.96 million

$4,962,468.00

Sector

Saúde

Industry

Materiais e Equipamentos Médicos

revenue by Business Segment Edwards Lifesciences

EW revenue and profits

Financial Results EW

DRAG THE FRAME TO SEE MORE DATA

EW cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$77.63 34,88% (12M)

P/E

46.88

2.46%

ROE

3.78%

P/BV

1.77

CI - Cigna

$272.65 --5,23% (12M)

P/E

11.58

2.16%

ROE

15.39%

P/BV

1.78

CNC - Centene

$37.26 38,72% (12M)

P/E

-4.98

0.00%

ROE

-29.93%

P/BV

1.49

HUM - Humana

$196.30 --14,19% (12M)

P/E

42.07

0.89%

ROE

6.06%

P/BV

2.55

SNY - Sanofi

$47.64 --3,72% (12M)

P/E

7.21

4.00%

ROE

17.79%

P/BV

1.28

LLY - Eli Lilly

$923.03 21,62% (12M)

P/E

41.74

0.55%

ROE

81.02%

P/BV

33.82

HCA - HCA Healthcare

$498.78 47,18% (12M)

P/E

12.41

0.80%

ROE

-228.14%

P/BV

-28.31

NVS - Novartis

$153.41 34,63% (12M)

P/E

21.74

2.01%

ROE

34.77%

P/BV

7.56